2007
DOI: 10.1074/jbc.m701781200
|View full text |Cite
|
Sign up to set email alerts
|

Further Evidence for Two Functional Forms of Prothrombinase Each Specific for Either of the Two Prothrombin Activation Cleavages

Abstract: Previous work showed that prothrombin derivatives cleavable only at Arg-320 (rMZ) or Arg-271 (rP2) are partial, rather than competitive, inhibitors of prothrombin activation by prothrombinase. A "ping-pong"-like model, which posits two equilibrating forms of prothrombinase, explained the inhibition pattern. The present studies were undertaken to further investigate this putative mechanism. Two models were developed, one allowing for one form of the enzyme and the other allowing for two forms. Both models also … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
59
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(60 citation statements)
references
References 42 publications
1
59
0
Order By: Relevance
“…In contrast to the interpretations outlined here, it has alternately been proposed that the recognition and cleavage of the two bonds in prothrombin is accomplished by two different isoforms of prothrombinase that are differentially specific for the two sites (10,11). This alternate interpretation, which requires that the affinity of prothrombinase for the substrate is cleavage site-dependent, is inconsistent with a series of kinetic findings and with the fact that II QQ is a classical competitive inhibitor of all possible half-reactions of prothrombin activation (12).…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…In contrast to the interpretations outlined here, it has alternately been proposed that the recognition and cleavage of the two bonds in prothrombin is accomplished by two different isoforms of prothrombinase that are differentially specific for the two sites (10,11). This alternate interpretation, which requires that the affinity of prothrombinase for the substrate is cleavage site-dependent, is inconsistent with a series of kinetic findings and with the fact that II QQ is a classical competitive inhibitor of all possible half-reactions of prothrombin activation (12).…”
Section: Discussionmentioning
confidence: 72%
“…Meizothrombin (mIIa), 3 produced as the sole detectable intermediate, accumulates transiently at concentrations in vast excess over the concentration of enzyme and cleavage of the two bonds in the opposite order is below experimental limits of detection (9,10). Although recent studies indicate that some intermediate produced via the alternate pathway can be detected (11), it is clear that both cleavage sites in prothrombin are accessible to externally added proteinase, yet prothrombinase preferentially rec-* This work was supported by National Institutes of Health Grants HL-74124 (to S. K., and R. M. C.), HL-47465 (to S. K.), HL-038779 (to P. E. B.…”
mentioning
confidence: 99%
“…Kinetic modeling studies have led to the proposal that both ratcheting of substrate and two interconverting forms of prothrombinase are responsible for the two cleavage reactions (57). The rate constants proposed for a possible ratcheting step are Ͼ20-fold slower than those shown by the present direct measurement and represented as unidirectional (57).…”
Section: Discussionmentioning
confidence: 82%
“…Kinetic modeling studies have led to the proposal that both ratcheting of substrate and two interconverting forms of prothrombinase are responsible for the two cleavage reactions (57). The rate constants proposed for a possible ratcheting step are Ͼ20-fold slower than those shown by the present direct measurement and represented as unidirectional (57). Alternatively, others have argued that the equilibrium between E* and E detected in Na ϩ binding studies with mIIa⌬F1 need to be accounted for in explaining the pathway of prothrombin activation (51).…”
Section: Discussionmentioning
confidence: 99%
“…Active centre formed in molecule of produced MT. As was shown previously, during the first minute of clotting system activation in vitro levels of both FIIa and MT are equal and can reach 0.8 μM [2]. Moreover, MT can bind to platelet membrane [8], so local concentration of MT near platelet surface may be significantly increased during the initial activation stage.…”
Section: Discussionmentioning
confidence: 59%